Jazz Pharmaceuticals plc (NASDAQ: JAZZ) filed an order in New Jersey’s District Court stating that it had dismissed the last of the patent claims against the company’s cannabis epilepsy drug Epidiolex. Jazz acquired the company GW Pharmaceuticals which had developed Epidiolex for the treatment of rare pediatric epilepsy conditions Dravet… …
Trulieve Opening 162nd Florida Medical Cannabis Dispensary
The new retail facility in Middleburg (Clay County) will host a grand opening celebration on Feb. 14. …
Rubicon Organics Obtains Key Certification for International Export
The company’s dried cannabis products are now compliant with the World Health Organization’s guidelines on GACP medicinal plants. …
Tilray Expands Medical Cannabis Portfolio in Germany
The company launched new cannabis extract products and formulations. …